Skip to main content
Clinical Trials/JPRN-UMIN000040185
JPRN-UMIN000040185
Recruiting
未知

Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease - COVID-19 in patients with hepatobiliary-pancreatic disease

Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine0 sites600 target enrollmentApril 17, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
COVID-19 Hepatobiliary-pancreatic disease
Sponsor
Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Enrollment
600
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 17, 2020
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The following cases willn be excluded from both the control group and the hepatobiliary\-pancreatic disease group (1\) If the patient requests that they do not wish to cooperate to this study (2\) HIV patients (3\) Patients with severe other organ failure (4\) Patients with advanced cancer of other organs

Outcomes

Primary Outcomes

Not specified

Similar Trials